IBSAX
Price
$14.48
Change
+$0.25 (+1.76%)
Updated
Sep 8 closing price
Net Assets
342.46M
JDMRX
Price
$130.26
Change
+$0.05 (+0.04%)
Updated
Sep 5 closing price
Net Assets
23.41B
Interact to see
Advertisement

IBSAX vs JDMRX

Header iconIBSAX vs JDMRX Comparison
Open Charts IBSAX vs JDMRXBanner chart's image
VY® Baron Growth A
Price$14.48
Change+$0.25 (+1.76%)
VolumeN/A
Net Assets342.46M
Janus Henderson Enterprise R
Price$130.26
Change+$0.05 (+0.04%)
VolumeN/A
Net Assets23.41B
IBSAX vs JDMRX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
IBSAX vs. JDMRX commentary
Sep 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IBSAX is a Buy and JDMRX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JDMRX has more cash in the bank: 23.4B vs. IBSAX (342M). JDMRX pays higher dividends than IBSAX: JDMRX (0.56) vs IBSAX (0.06). IBSAX was incepted earlier than JDMRX: IBSAX (23 years) vs JDMRX (16 years). IBSAX (1.62) is less costly to investors than JDMRX (1.42). JDMRX is a more actively managed with annual turnover of: 15.00 vs. IBSAX (4.00). IBSAX has a lower initial minimum investment than JDMRX: IBSAX (0) vs JDMRX (2500). JDMRX annual gain was more profitable for investors over the last year : 2.26 vs. IBSAX (-27.14). JDMRX return over 5 years is better than : -1.95 vs. IBSAX (-32.28).
IBSAXJDMRXIBSAX / JDMRX
Total Expense Ratio1.501.42106%
Annual Report Gross Expense Ratio1.621.42114%
Fund Existence23 years16 years-
Gain YTD-27.9775.551-504%
Front LoadN/AN/A-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets342M23.4B1%
Annual Yield % from dividends0.060.5610%
Returns for 1 year-27.142.26-1,199%
Returns for 3 years-21.5010.18-211%
Returns for 5 years-32.28-1.951,659%
Returns for 10 years-46.3453.71-86%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ETIHX40.600.51
+1.27%
Eventide Healthcare & Life Sciences I
ZVNIX43.030.22
+0.51%
Zevenbergen Growth Institutional
FKIDX16.790.05
+0.30%
Fidelity Diversified Intl K6
AGTHX86.220.21
+0.24%
American Funds Growth Fund of Amer A
DNLYX62.46-0.01
-0.02%
BNY Mellon Active MidCap Y